Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, announced that it will be supporting the first International Scar Treatment Conference in Israel, which will be held in Tel Aviv, on February 22nd, 2017.
Lumenis is proud to be exhibiting as a gold level sponsor at the 42nd Annual Boswick Burn and Wound Symposium in Wailea-Maui, Hawaii.
HRH The Duke of Sussex visits The Queen Elizabeth Hospital in Birmingham Scar Center
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF).
Scars result from a chaotic wound healing response leaving behind fibrotic tissue due to irregular collagen formation. There are different types of scar including atrophic, hypertrophic, contracture and keloid scars. Available scar revision therapies depend on the type of scar, and range from topical creams for mild scarring, to grafting in the case of large, traumatic scars. Laser scar revision is an effective method for treating a wide range of scars that improves skin texture and pigment as well as functional aspects.
For acne and some surgical scars (see also Acne Scars Treatment), fractional skin resurfacing can effectively treat textural and pigment concerns. IPL can also be used to decrease pigmentation and vascular effects. Scars caused by burns and other traumatic injuries are more complicated in nature and can negatively affect the quality of life due to disfigurement, pain, bleeding, pruritis (itching) and restricted range of motion. Fractional ablative laser resurfacing has been proven to effectively treat such scars and provide consistent and significant functional improvement as well as measurable cosmetic benefits.
A Trusted Path To Superior Outcomes